Sort
15,273 grants matching “antimicrobial resistance”
Dendritic Cell Restriction and Innate Immune Sensing of HIV Infection
$253,500Dan R Littman · New York University School Of Medicine · R21 · FY2010 · AI
Recombination-quiescent genes & phylogenic validation of encoded vaccine targets
$253,500Richard Goldstein · Boston Medical Center · R21 · FY2010 · AI
Infectious Diseases Fellowship Program
$253,481Christa Zerbe · National Institute Of Allergy And Infectious Diseases · ZIE · FY2020 · AI
Task X13: Product Characterization and Process Development
$253,402James Richardson · Advanced Bioscience Laboratories, Inc. · N01 · FY2015 · AI
Novel Antimicrobials: Salivary MUC7 Peptides
$253,312State University Of New York At Buffalo · R01 · FY2005 · DE
Bordetella cell surface modification and pathogenesis
$253,250Rajendar K Deora · Ohio State University · R21 · FY2021 · AI
Contribution of macrophages to Neisseria gonorrhoeae pathogenesis
$253,176Ana-Maria Dragoi · Louisiana State Univ Hsc Shreveport · P20 · FY2022 · GM
The Role of Enterococcus Unique Hypothetical EF1909 in Intrinsic β-lactam Resistance
$253,000Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · R21 · FY2022 · AI
Nanoparticle-based Antimicrobial Photochemotherapy in Biofilms
$252,800Nikolaos Soukos · Ada Forsyth Institute, Inc. · R21 · FY2009 · DE
ASSESSING IN VITRO/VIVO EFFICACY OF ANTIMALARIAL ENR INHIBITORS
$252,773David Armand Fidock · Texas A&M Agrilife Research · P01 · FY2007 · AI
Tau-binding B Cells in Alzheimer's Disease
$252,750Thomas L Rothstein · Feinstein Institute For Medical Research · R21 · FY2015 · AG
Urovirulence and fimbrial regulation in Klebsiella quasipneumoniae
$252,720Nicole Janell De Nisco · University Of Texas Dallas · R21 · FY2023 · AI
Development of Aminoglycoside-Nucleic Acid Conjugates for Inactivation of an Antibiotic Resistance-Conferring Aminoglycoside Sensing Riboswitch
$252,413Meredith Newby Spano · Nubad, Llc · R43 · FY2015 · AI
The ClpP protease as a therapeutic target in bacterial and mammalian cells
$252,397Michael Maurizi · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Infectious Disease Training in Clinical Investigation
$252,234Phillip Keith Peterson · University Of Minnesota · T32 · FY2006 · AI
The Great Diseases: Bridging biomedical career exploration, competency building and mentoring
$252,205Berri H Jacque · Tufts University Boston · R25 · FY2024 · GM
The Psa fimbriae of Yersinia pestis, an adhesin with protective immunogenic prope
$252,201Dieter M. Schifferli · University Of Pennsylvania · R21 · FY2009 · AI
Project 2: Impact of Antibiotics on Growth Cycle and Toxin Production in S. aureus
$252,200Devin Dean Bolz · Idaho Veterans Research / Education Fdn · P20 · FY2016 · GM
Project 2: Impact of Antibiotics on Growth Cycle and Toxin Production in S. aureus
$252,200Devin Dean Bolz · Idaho Veterans Research / Education Fdn · P20 · FY2019 · GM
Project 2: Impact of Antibiotics on Growth Cycle and Toxin Production in S. aureus
$252,200Devin Dean Bolz · Idaho Veterans Research / Education Fdn · P20 · FY2018 · GM
Development of Novel Therapeutics for Treatment of Mycobacterial Infections
$252,199Elton Jeffrey North · Creighton University · P20 · FY2022 · GM
Novel cyclic lipopeptides for treating gram negative bacterial infections
$252,175Richard A Houghten · Torrey Pines Inst For Molecular Studies · R21 · FY2016 · AI
Membrane Active Peptides
$252,132Rice University · R01 · FY2005 · GM
Preventing outbreaks of foodborne pathogenic bacteria in edible sprouts via novel resistance-conferring seed treatments
$252,130Murli Manohar · Ascribe Bioscience Inc. · R41 · FY2020 · AI
Instant Antimicrobial Susceptibility Test
$252,128Pawan Rao · Lenima Field Diagnostics, Llc · R43 · FY2020 · AI